XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Ordinary Shares
Euro Deferred Shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Shareholders' equity, beginning balance (in shares) at Dec. 31, 2019   226,802,609        
Shareholders' equity, beginning balance (in shares) at Dec. 31, 2019     4,000,000      
Shareholders' equity, beginning balance at Dec. 31, 2019 $ (866,544) $ 23 $ 45 $ 8,904,692 $ (9,552,214) $ (219,090)
Increase (Decrease) in Stockholders' Equity            
Net (loss) income 183,944       183,944  
Other comprehensive income (loss) 1,337         1,337
Compensation related to share-based awards 41,357     41,357    
Ordinary shares issued (in shares)   3,513,159        
Tax withholding for restricted shares (8,036)     (8,036)    
Other 3   $ 4 (1)    
Shareholders' equity, ending balance (in shares) at Dec. 31, 2020     4,000,000      
Shareholders' equity, ending balance (in shares) at Dec. 31, 2020   230,315,768        
Shareholders' equity, ending balance at Dec. 31, 2020 (647,939) $ 23 $ 49 8,938,012 (9,368,270) (217,753)
Increase (Decrease) in Stockholders' Equity            
Net (loss) income (613,245)       (613,245)  
Other comprehensive income (loss) 1,308         1,308
Compensation related to share-based awards $ 30,046     30,046    
Exercise of options (in shares) 82,331 82,331        
Exercise of options $ 622     622    
Ordinary shares issued (in shares)   3,292,717        
Tax withholding for restricted shares (14,774)     (14,774)    
Other $ (4)   $ (4)      
Shareholders' equity, ending balance (in shares) at Dec. 31, 2021     4,000,000      
Shareholders' equity, ending balance (in shares) at Dec. 31, 2021 233,690,816 233,690,816        
Shareholders' equity, ending balance at Dec. 31, 2021 $ (1,243,986) $ 23 $ 45 8,953,906 (9,981,515) (216,445)
Increase (Decrease) in Stockholders' Equity            
Net (loss) income (2,923,105)       (2,923,105)  
Other comprehensive income (loss) (10,496)         (10,496)
Compensation related to share-based awards 17,314     17,314    
Ordinary shares issued 0 $ 1   (1)    
Ordinary shares issued (in shares)   1,517,223        
Tax withholding for restricted shares (1,898)     (1,898)    
Other $ (1)   $ (2) 1    
Shareholders' equity, ending balance (in shares) at Dec. 31, 2022     4,000,000      
Shareholders' equity, ending balance (in shares) at Dec. 31, 2022 235,208,039 235,208,039        
Shareholders' equity, ending balance at Dec. 31, 2022 $ (4,162,172) $ 24 $ 43 $ 8,969,322 $ (12,904,620) $ (226,941)